A C/T polymorphism in the 5′-untranslated region of the CD40 gene is associated with Graves' disease in Koreans

被引:68
作者
Kim, TY
Park, YJ
Hwang, JK
Song, JY
Park, KS
Cho, BY
Park, DJ
机构
[1] Seoul Natl Univ Hosp, Dept Internal Med, Clin Res Inst, Seoul 110744, South Korea
[2] Seoul Natl Univ, Coll Med, Dept Internal Med, Seoul, South Korea
[3] Seoul Natl Univ, Med Res Ctr, Inst Endocrinol Nutr & Metab, Seoul, South Korea
[4] Gil Med Ctr, Gachon Med Sch, Div Endocrinol & Metab, Inchon, South Korea
关键词
D O I
10.1089/105072503322511319
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
The genetic loci conferring susceptibility to Graves' disease remain unclear. The aim of the present study was to examine a C/T polymorphism in the 5'-untranslated region of the CD40 gene and its relationship with autoimmune thyroid diseases in Koreans. The C/T polymorphism in the 5'-untranslated region of CD40 gene, clinical characteristics, and thyroid antibodies were analyzed in a series of Korean patients (132 with Graves' disease, 118 with Hashimoto's thyroiditis, and 164 normal controls). The CC genotype was significantly associated with Graves' disease (odds ratio, 1.93; 95% confidence interval, 1.21-3.09; corrected p = 0.019). On the other hand, the frequency of the TT genotype was significantly lower in Graves' patients than in controls (8% vs. 18%; odds ratio, 0.38; 95% confidence interval, 0.18-0.82; corrected p = 0.044). Allele frequencies in CD40 did not differ from controls in patients with Hashimoto's thyroiditis. In patients with Graves' disease, there were significant differences between genotypic groups in the activity of stimulating thyrotropin (TSH) receptor antibody. However, clinical characteristics and other thyroid antibodies were not significantly different. In conclusion, the C allele in the 5'-untranslated region of the CD40 gene may confer genetic susceptibility to Graves' disease in Koreans.
引用
收藏
页码:919 / 925
页数:7
相关论文
共 26 条
[1]   Kozak sequence polymorphism of the glycoprotein (GP) Ibα gene is a major determinant of the plasma membrane levels of the platelet GP Ib-IX-V complex [J].
Afshar-Kharghan, V ;
Li, CQ ;
Khoshnevis-Asl, M ;
López, JA .
BLOOD, 1999, 94 (01) :186-191
[2]   THE CD40 ANTIGEN AND ITS LIGAND [J].
BANCHEREAU, J ;
BAZAN, F ;
BLANCHARD, D ;
BRIERE, F ;
GALIZZI, JP ;
VANKOOTEN, C ;
LIU, YJ ;
ROUSSET, F ;
SAELAND, S .
ANNUAL REVIEW OF IMMUNOLOGY, 1994, 12 :881-922
[3]   What is the evidence of genetic factors in the etiology of Graves' disease? A brief review [J].
Brix, TH ;
Kyvik, KO ;
Hegedus, L .
THYROID, 1998, 8 (08) :727-734
[4]  
Clark LB, 1996, ADV IMMUNOL, V63, P43
[5]  
DORIA G, 2002, IMMUNOLOGICALLY MED, P1
[6]   Immune regulation by CD40 and its ligand GP39 [J].
Foy, TM ;
Aruffo, A ;
Bajorath, J ;
Buhlmann, JE ;
Noelle, RJ .
ANNUAL REVIEW OF IMMUNOLOGY, 1996, 14 :591-617
[7]   A common polymorphism in the annexin V Kozak sequence (-1C>T) increases translation efficiency and plasma levels of annexin V, and decreases the risk of myocardial infarction in young patients [J].
González-Conejero, R ;
Corral, J ;
Roldán, V ;
Martínez, C ;
Marín, F ;
Rivera, J ;
Iniesta, JA ;
Lozano, ML ;
Marco, P ;
Vicente, V .
BLOOD, 2002, 100 (06) :2081-2086
[8]   A common genetic polymorphism (46 C to T substitution) in the 5′-untranslated region of the coagulation factor XII gene is associated with low translation efficiency and decrease in plasma factor XII level [J].
Kanaji, T ;
Okamura, T ;
Osaki, K ;
Kuroiwa, M ;
Shimoda, K ;
Hamasaki, N ;
Niho, Y .
BLOOD, 1998, 91 (06) :2010-2014
[9]   The prevalence and clinical significance of blocking thyrotropin receptor antibodies in untreated hyperthyroid Graves' disease [J].
Kim, WB ;
Chung, HK ;
Park, YJ ;
Park, DJ ;
Tahara, K ;
Kohn, LD ;
Cho, BY .
THYROID, 2000, 10 (07) :579-586
[10]   Remission of Graves' hyperthyroidism and A/G polymorphism at position 49 in exon 1 of cytotoxic T lymphocyte-associated molecule-4 gene [J].
Kinjo, Y ;
Takasu, N ;
Komiya, I ;
Tomoyose, T ;
Takara, M ;
Kouki, T ;
Shimajiri, Y ;
Yabiku, K ;
Yoshimura, H .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2002, 87 (06) :2593-2596